Cancer costs UK businesses £1.6bn in absences

15 weeks taken off in employees’ cancer journey

Cameron Roberts
clock • 1 min read

Cancer support service firm, Reframe Cancer, conducted research that shows absences due to cancer will cost UK business £1.6 billion in 2024.

The research, that spoke to 500 UK employees with cancer, uncovered that the average employee will be absent from work for 15 weeks. This time off includes: Pre-diagnosis worries and symptoms: 12 days Diagnosis and testing: 16 days Treatment: 24 days Recovery: 23 days The research also showed the point at which employees told their employer, 55% told their employer after their cancer diagnosis was been confirmed; 18% disclose when undergoing tests; and 11% wait until they are undergoing treatment or when treatment has finished. Mark Stephenson, CEO, Reframe Cancer, said: "...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual PMI

Bupa to launch Cancer Specialist Centres

Bupa to launch Cancer Specialist Centres

Gynaecology and gastroenterology focus

Cameron Roberts
clock 17 December 2025 • 1 min read
Bupa UK and Nuffield Health agree new contract

Bupa UK and Nuffield Health agree new contract

Bupa customers given access to Nuffield solutions

Cameron Roberts
clock 15 December 2025 • 1 min read
Vitality partners with Lloyds for health offering

Vitality partners with Lloyds for health offering

D2C health plan

Cameron Roberts
clock 10 December 2025 • 2 min read